Vinay Mathew Thomas, MBBS

Vinay Mathew Thomas practices at Castleview Hospital in Price, Utah, part of Lifepoint Health.

Vinay Mathew Thomas' NPI, 1255869699, was assigned on May 30, 2017. Vinay Mathew Thomas holds Utah license 12256053-1205.

Vinay Mathew Thomas' primary practice is Castleview Hospital, at 300 North Hospital Drive, Price, UT 84501 in Carbon County. The practice phone is (435) 637-4800.

Vinay Mathew Thomas' primary practice is Castleview Hospital in Price, Utah, part of Lifepoint Health. Vinay Mathew Thomas is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Vinay Mathew Thomas to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Vinay Mathew Thomas practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Vinay Mathew Thomas' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Vinay Mathew Thomas is licensed in Utah.

CMS data shows 310 Medicare services from Vinay Mathew Thomas across 5 procedure codes in 2024, for 70 Medicare patients. Medicare paid $17,160 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 70 Medicare patients who saw Vinay Mathew Thomas in 2024. The largest group is 65 to 74, with 34 patients. 63% of them have high blood pressure, and 56% have high cholesterol. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Vinay Mathew Thomas' median patient age at 73, with 27% women.

In 2024, Vinay Mathew Thomas wrote 76 Medicare Part D claims for 28 patients. 64% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $90 in total drug cost. In 2020, CMS named 85 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Vinay Mathew Thomas for performance year 2024, reported as part of a group. Vinay Mathew Thomas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Vinay Mathew Thomas as offering telehealth.

Dmand AI links 24 papers to Vinay Mathew Thomas, published from 2019 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Carcinoma, Transitional Cell, Prostatic Neoplasms and Urinary Bladder Neoplasms. Vinay Mathew Thomas has published most often in Cureus. Vinay Mathew Thomas' most frequent co-authors are Benjamin Louis Maughan, MD, Haoran Li, MD, PhD and Neeraj Agarwal, MD.

CMS Open Payments shows 6 general payments to Vinay Mathew Thomas from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 89% of the total. Exelixis Inc. paid the most, $518.